Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03123263 · ClinicalTrials.gov registry record
Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer
A clinical trial, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Completed
- Registry status
- 60
- Enrollment target
NCT03123263: Completed study, sponsored by Texas Tech University Health Sciences Center, El Paso.
NCT03123263 is a clinical trial that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03123263 has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study retrospectively looks at changes in Echocardiographic parameters while using transtuzumab
Primary Outcome
LV ejection fraction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2019-02-26 |
What the finished NCT03123263 record still lists
NCT03123263 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03123263 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03123263 about?
NCT03123263 is a clinical study titled "Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer". This study retrospectively looks at changes in Echocardiographic parameters while using transtuzumab
What is the current status of trial NCT03123263?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2017-04-11. Estimated completion is 2019-02-26.
Who is sponsoring clinical trial NCT03123263?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI